Evidence map›Paper›PMID 31856419›Full record

ArticleESC heart failure2020

Dilated cardiomyopathy and aldosteronoma: a causal link?

Jiyu Zhang, Jin Yang, Yueliang Li

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in ESC heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jiyu ZhangDepartment of Cardiovascular Disease, Central Hospital of Panzhihua City, Panzhihua, Sichuan, Province, 617000, China.
Jin YangDepartment of Cardiovascular Disease, Central Hospital of Panzhihua City, Panzhihua, Sichuan, Province, 617000, China.
Yueliang LiDepartment of Cardiovascular Disease, Qingyuan People's Hospital, Qingyuan, Guangdong, Province, 511500, China.
Panzhihua Central Hospital · CNQingzhou City People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study is to reveal the causal relationship between dilated cardiomyopathy and aldosteronoma. A 44-year-old male dilated cardiomyopathy patient with aldosteronoma, who demonstrated a worse cardiac function after 1 year therapy with optimized dosage of sacubirtil/valsartan, furosemide, metoprolol, and spironolactone. The patient shows a promising prognosis after aldosteronoma removal procedure. Aldosteronoma may cause dilated cardiomyopathy. We assume that the optimal treatment for aldosteronoma-induced dilated cardiomyopathy is surgical removal combined with drugs.

Indexed as

Adrenal Gland NeoplasmsAdultBiopsyCardiomyopathy, DilatedDiagnosis, DifferentialEchocardiographyHumansHyperparathyroidismMalePrognosisTomography, X-Ray ComputedVentricular Function, LeftAldosteronomaDilated cardiomyopathySacubitril/valsartan

Identifiers

PMID31856419
PMCPMC7083418
OpenAlexW2995558557

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.